Back
Biomarin Pharmaceutical Vs. Pro-Dex Industry Stock Comparison
Buy
65
BMRN
Biomarin Pharmaceutical
Last Price:
$67.87
Seasonality Move:
9.08%
Buy
68
PDEX
Pro-Dex
Last Price:
$51.49
Seasonality Move:
10.27%
Buy
65
Biomarin Pharmaceutical (BMRN)
is a Buy
Is Biomarin Pharmaceutical a Buy, Sell or Hold?
-
The current Biomarin Pharmaceutical [BMRN] share price is $67.90. The Score for BMRN is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
-
BMRN is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
BMRN Stock Price Chart
What is Biomarin Pharmaceutical's stock price today?
-
The Biomarin Pharmaceutical share price today is $67.90Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BMRN is experiencing slight buying pressure.
BMRN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.25 | Buy |
Relative Strength Index (14 RSI): | 58.77 | Buy |
Chaikin Money Flow: | 27741 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (65.18 - 67.1) | Buy |
Bollinger Bands (100): | (62.89 - 81.37) | Sell |
PDEX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.3 | Buy |
Relative Strength Index (14 RSI): | 55.69 | Buy |
Chaikin Money Flow: | -20256 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (46.32 - 52.22) | Buy |
Bollinger Bands (100): | (24.46 - 47.06) | Buy |
BMRN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 66.67 | Buy |
20-day SMA: | 66.29 | Buy |
50-day SMA: | 65.97 | Buy |
200-day SMA: | 78 | Sell |
8-day EMA: | 66.79 | Buy |
20-day EMA: | 66.36 | Buy |
50-day EMA: | 67.3 | Buy |
200-day EMA: | 76.03 | Sell |
PDEX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 49.35 | Buy |
20-day SMA: | 48.53 | Buy |
50-day SMA: | 45.81 | Buy |
200-day SMA: | 27.28 | Buy |
8-day EMA: | 50.13 | Buy |
20-day EMA: | 48.86 | Buy |
50-day EMA: | 44.85 | Buy |
200-day EMA: | 31.31 | Buy |
Biomarin Pharmaceutical Earnings Growth & BMRN Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.27 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.88 per share, and an increase next year of $1.01 per share.
Pro-Dex Earnings Growth & PDEX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.50 per share, and an increase next year of $0.06 per share.
Biomarin Pharmaceutical Technical Analysis
Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Pro-Dex Technical Analysis
Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |